Clinical Trial Update: A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Pataday Once Daily Relief Extra Strength to Claritin for allergic conjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Claritin® Tablets (Loratadine)
• Pataday® Once Daily Relief Extra Strength

Snippet

Sponsor: Andover Research Eye Institute | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED